Legal & General Group Plc increased its position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 40.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 358,432 shares of the company's stock after purchasing an additional 103,464 shares during the quarter. Legal & General Group Plc owned approximately 0.23% of Tempus AI worth $12,101,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of TEM. Envestnet Asset Management Inc. raised its stake in shares of Tempus AI by 157.7% in the 4th quarter. Envestnet Asset Management Inc. now owns 44,119 shares of the company's stock valued at $1,489,000 after buying an additional 26,998 shares in the last quarter. Wells Fargo & Company MN raised its position in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares in the last quarter. ExodusPoint Capital Management LP bought a new position in Tempus AI during the fourth quarter worth about $1,916,000. Massachusetts Financial Services Co. MA bought a new stake in shares of Tempus AI in the 4th quarter valued at approximately $10,148,000. Finally, StoneX Group Inc. acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $527,000. Institutional investors and hedge funds own 24.22% of the company's stock.
Insiders Place Their Bets
In related news, EVP Erik Phelps sold 5,934 shares of the business's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $67.57, for a total value of $400,960.38. Following the completion of the transaction, the executive vice president now owns 214,662 shares of the company's stock, valued at $14,504,711.34. The trade was a 2.69 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the company's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares of the company's stock, valued at approximately $3,434,220. This trade represents a 19.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,146,249 shares of company stock worth $301,185,058 in the last 90 days.
Tempus AI Stock Down 1.1 %
Shares of Tempus AI stock traded down $0.44 on Friday, hitting $40.42. The stock had a trading volume of 4,560,129 shares, compared to its average volume of 5,515,313. The business's 50 day moving average is $54.10 and its two-hundred day moving average is $50.60. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on TEM shares. TD Cowen reissued a "buy" rating and issued a $74.00 target price (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. William Blair reissued a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Bank of America raised their target price on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and upped their price target for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Finally, Guggenheim reissued a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $61.18.
Check Out Our Latest Report on TEM
About Tempus AI
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
